Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

1.42
-0.0300-2.07%
Volume:2.18M
Turnover:3.13M
Market Cap:308.52M
PE:-1.07
High:1.49
Open:1.41
Low:1.39
Close:1.45
Loading ...
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Major Issues Report

Form 8-K - Current report
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2023

Correspondence

Form CORRESP - Correspondence
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 26, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 18, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 16, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Jun 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities